Biogen (BIIB) option implied volatility increases, shares plunge 28% after discontinuing Alzheimer's trials

March 21, 2019 10:06 AM

Biogen (NASDAQ: BIIB) April call option implied volatility is at 38; compared to its 52-week range of 21 to 45 shares plunge 28% after discontinuing Alzheimer's trials.

Categories

Options

Next Articles